财报披露
MDxHealth(MDXH)03-13 05:05
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-021880 Act: 34 Size: 46 KB 网页链接
简介:MDxHealth SA是分子诊断领域的领导者,是一家开发和商业化用于癌症评估和患者个性化治疗的先进表观遗传分析和服务测试的公司。MDxHealth SA成立于2003年1月10日。该活动围绕两个产品家族组织:(1)表观遗传分子检测(ConfirmMDx):有用和创新的检测,使研究人员能够正确识别前列腺癌并进行治疗;(2)非侵入性液体活检检测(SelectMDx):在活检期间评估患侵袭性前列腺癌风险的检测。
今开:2.48 | 昨收:2.49 |
最高:2.59 | 最低:2.4552 |
涨停价: | 跌停价: |
总市值:67401590 |
MDxHealth(MDXH)03-13 05:05
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-021880 Act: 34 Size: 46 KB 网页链接
MDxHealth(MDXH)02-17 05:15
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-014899 Act: 34 Size: 18 KB 网页链接
MDxHealth(MDXH)02-15 04:45
$MDxHealth(MDXH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000021 Act: 34 Size: 41 KB 网页链接
MDxHealth(MDXH)03-07 06:25
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-020488 Act: 34 Size: 111 KB 网页链接
不入流资讯2023-08-10 17:03
$MDxHealth(MDXH)$ MDxHealth shares up 17% premarket as Cigna expands commercial and Medicare Advantage coverage to include the Co.'s select MDX for prostate cancer test查看全文
医业观察星哥2022-08-10 00:32
点击关注我们
有观点,有态度
这是医业观察的第1504-3期文章
来源:医疗器械创新网
//
近日,精密诊断公司 MDxHealth 以高达 1 亿美元的价格从 Exact Sciences 收购了 Oncotype DX Genomic Prostate Score (GPS) test。
根据两家公司签署的资产购买协议条款...查看全文
IPO捕手2021-11-04 17:55
今年年中,各股均迎来密集上市热潮,美股迎来中概股密集上市,内地企业赴港首次公开募股也保持空前势头。下面IPO捕手汇总了11月4日IPO市场动态,供大家参考~
(以下消息来自:36氪、界面新闻、网易新闻等)
【港股】
合能控股申请赴港IPO,老牌上市意欲何为
据港交所10月31日披露...查看全文
格隆汇11月4日丨比利时商用阶段精准诊断公司MDxHealth(MDXH.US)今天纳斯达克上市,以13.46美元的价格发行380万股,筹集5000万美元。公司市值约为21美元。 MDxHealth创立于2003年,总部位于比利时,是一家商业阶段的精准诊断公司,致力... 网页链接
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-021880 Act: 34 Size: 46 KB 网页链接
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-020488 Act: 34 Size: 111 KB 网页链接
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-014899 Act: 34 Size: 18 KB 网页链接
$MDxHealth(MDXH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000021 Act: 34 Size: 41 KB 网页链接
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-001933 Act: 34 Size: 31 KB 网页链接
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-096952 Act: 34 Size: 230 KB 网页链接
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-090210 Act: 34 Size: 32 KB 网页链接
$MDxHealth(MDXH)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000889 Act: 34 Size: 3 KB 网页链接
$MDxHealth(MDXH)$ 8-A12B/A [Amend] Registration of securities [Section 12(b)] Accession Number: 0001213900-23-089839 Act: 34 Size: 16 KB 网页链接
$MDxHealth(MDXH)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-087532 Act: 34 Size: 236 KB 网页链接